Manulife (Manufacturers Life Insurance)’s Procept Biorobotics PRCT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$5.49M Buy
95,302
+23,049
+32% +$1.33M ﹤0.01% 1122
2025
Q1
$4.21M Buy
72,253
+6,433
+10% +$375K ﹤0.01% 1237
2024
Q4
$5.3M Buy
65,820
+6,785
+11% +$546K ﹤0.01% 1179
2024
Q3
$4.73M Sell
59,035
-3,527
-6% -$283K ﹤0.01% 1236
2024
Q2
$3.82M Sell
62,562
-10,469
-14% -$640K ﹤0.01% 1278
2024
Q1
$3.61M Buy
73,031
+2,665
+4% +$132K ﹤0.01% 1314
2023
Q4
$2.95M Sell
70,366
-12,590
-15% -$528K ﹤0.01% 1348
2023
Q3
$2.72M Buy
82,956
+14,088
+20% +$462K ﹤0.01% 1342
2023
Q2
$2.43M Buy
68,868
+8,729
+15% +$309K ﹤0.01% 1351
2023
Q1
$1.71M Buy
60,139
+5,367
+10% +$152K ﹤0.01% 1441
2022
Q4
$2.25M Buy
54,772
+260
+0.5% +$10.7K ﹤0.01% 1351
2022
Q3
$2.22M Sell
54,512
-14,349
-21% -$584K ﹤0.01% 1357
2022
Q2
$2.21M Buy
68,861
+12,694
+23% +$408K ﹤0.01% 1397
2022
Q1
$1.95M Buy
+56,167
New +$1.95M ﹤0.01% 1515